Modeling Cancer with Pluripotent Stem Cells

被引：28
|
作者：
Gingold, Julian [1 ]
Zhou, Ruoji [2 ,3 ]
Lemischka, Ihor R. [4 ,5 ,6 ]
Lee, Dung-Fang [2 ,3 ,7 ]
机构：
[1] Cleveland Clin Fdn, Womens Hlth Inst, Cleveland, OH 44195 USA
[2] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA
[3] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA
[4] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA
[5] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA
[6] Icahn Sch Med Mt, Black Family Stem Cell Inst, New York, NY 10029 USA
[7] Univ Texas Hlth Sci Ctr Houston, Ctr Stem Cell & Regenerat Med, Brown Fdn, Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA
来源：
TRENDS IN CANCER | 2016年 / 2卷 / 09期
关键词：
TARGETED GENE CORRECTION; FUNCTIONAL HUMAN LIVER; KIDNEY ORGANOIDS; HUMAN ES; DIRECTED DIFFERENTIATION; PROGENITOR CELLS; SELF-RENEWAL; IPS CELLS; GENERATION; DISEASE;
D O I：
10.1016/j.trecan.2016.07.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The elucidation of cancer pathogenesis has been hindered by limited access to patient samples, tumor heterogeneity, and the lack of reliable model organisms. Characterized by their ability to self-renew indefinitely and differentiate into all adult cell lineages of an organism, pluripotent stem cells (PSCs), including ESCs and induced pluripotent stem cells (iPSCs), provide a powerful and unlimited source to generate differentiated cells that can be used to study disease biology, facilitate drug discovery and development, and provide key insights for developing personalized therapies. This article reviews the recent developments and technologies converting PSCs into clinically relevant model systems for cancer research.
引用
收藏
页码：485 / 494
页数：10
相关论文
共 50 条
  • [11] Investigation of Rett Syndrome Using Pluripotent Stem Cells
    Dajani, Rana
    Koo, Sung-Eun
    Sullivan, Gareth J.
    Park, In-Hyun
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (11) : 2446 - 2453
  • [12] INDUCED PLURIPOTENT STEM CELLS - HOPES, FEARS AND VISIONS
    Archacka, Karolina
    Grabowska, Iwona
    Ciemerych, Maria A.
    POSTEPY BIOLOGII KOMORKI, 2010, 37 (01) : 41 - 62
  • [13] From embryonic stem cells to induced pluripotent stem cells-Ready for clinical therapy?
    Hu, Jing
    Wang, Jimei
    CLINICAL TRANSPLANTATION, 2019, 33 (06)
  • [14] Chromatin structure of pluripotent stem cells and induced pluripotent stem cells
    Delgado-Olguin, Paul
    Recillas-Targa, Felix
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2011, 10 (01) : 37 - 49
  • [15] Pluripotent stem cell for modeling neurological diseases
    Yung, Jasmine Sum-Yee
    Tam, Paul Kwong-Hang
    Ngan, Elly Sau-Wai
    EXPERIMENTAL CELL RESEARCH, 2013, 319 (02) : 177 - 184
  • [16] Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells
    Naphade, Swati
    Tshilenge, Kizito-Tshitoko
    Ellerby, Lisa M.
    NEUROTHERAPEUTICS, 2019, 16 (04) : 979 - 998
  • [17] Modeling Neuropsychiatric and Neurodegenerative Diseases with induced Pluripotent Stem Cells
    LaMarca, Elizabeth A.
    Powell, Samuel K.
    Akbarian, Schahram
    Brennand, Kristen J.
    FRONTIERS IN PEDIATRICS, 2018, 6
  • [18] Challenges of Stem Cell Therapy for Spinal Cord Injury: Human Embryonic Stem Cells, Endogenous Neural Stem Cells, or Induced Pluripotent Stem Cells?
    Ronaghi, Mohammad
    Erceg, Slaven
    Moreno-Manzano, Victoria
    Stojkovic, Miodrag
    STEM CELLS, 2010, 28 (01) : 93 - 99
  • [19] Recent Advances in Therapeutic Applications of Induced Pluripotent Stem Cells
    Rami, Farzaneh
    Beni, Shamsi Naderi
    Kahnamooi, Mahboobeh Mojaver
    Rahimmanesh, Ilnaz
    Salehi, Ahmad Reza
    Salehi, Rasoul
    CELLULAR REPROGRAMMING, 2017, 19 (02) : 65 - 74
  • [20] How induced pluripotent stem cells are redefining personalized medicine
    Ferreira, Leonardo M. R.
    Mostajo-Radji, Mohammed A.
    GENE, 2013, 520 (01) : 1 - 6
12345